Christopher Schaber, COB, CEO & Pres, Director at Soligenix, holds 90.09K shares in Soligenix (Ticker: SNGX), holds 232.77K shares in Windtree Therapeutics (Ticker: WINT). Most recently, Christopher Schaber Bought ― shares of Soligenix on May 18, 2022 for an estimated value of 8.80K.